{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:38:13Z","timestamp":1792165093988,"version":"4.4.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,17]]},"DOI":"10.7759\/cureus.35102","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T16:02:32Z","timestamp":1676649752000},"source":"Crossref","is-referenced-by-count":4,"title":["Weight Loss of Over 100 lbs in a Patient of Prader-Willi Syndrome Treated With Glucagon-Like Peptide-1 (GLP-1) Agonists"],"prefix":"10.7759","author":[{"given":"Sana","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arooj","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/genes10090713","article-title":"The Global Prader-Willi Syndrome Registry: development, launch, and early demographics","volume":"10","author":"Bohonowych J","year":"2019","unstructured":"Bohonowych J, Miller J, McCandless SE, Strong TV. The Global Prader-Willi Syndrome Registry: development, launch, and early demographics. Genes (Basel). 2019, 10:3-7. 10.3390\/genes10090713","journal-title":"Genes (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome - clinical genetics, diagnosis and treatment approaches: an update","volume":"15","author":"Butler MG","year":"2019","unstructured":"Butler MG, Miller JL, Forster JL. Prader-Willi syndrome - clinical genetics, diagnosis and treatment approaches: an update. Curr Pediatr Rev. 2019, 15:207-44. 10.2174\/1573396315666190716120925","journal-title":"Curr Pediatr Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy SB","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012, 14:10-26. 10.1038\/gim.0b013e31822bead0","journal-title":"Genet Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/138920211795677877","article-title":"Prader-Willi syndrome: obesity due to genomic imprinting","volume":"12","author":"Butler MG","year":"2011","unstructured":"Butler MG. Prader-Willi syndrome: obesity due to genomic imprinting. Curr Genomics. 2011, 12:204-15. 10.2174\/138920211795677877","journal-title":"Curr Genomics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S141352","article-title":"Obesity management in Prader-Willi syndrome: current perspectives","volume":"11","author":"Crin\u00f2 A","year":"2018","unstructured":"Crin\u00f2 A, Fintini D, Bocchini S, Grugni G. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes. 2018, 11:579-93. 10.2147\/DMSO.S141352","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/NT.0000000000000092","article-title":"Body mass index: obesity, BMI, and health: a critical review","volume":"50","author":"Nuttall FQ","year":"2015","unstructured":"Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015, 50:117-28. 10.1097\/NT.0000000000000092","journal-title":"Nutr Today"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1124\/pr.108.000604","article-title":"The role of incretins in glucose homeostasis and diabetes treatment","volume":"60","author":"Kim W","year":"2008","unstructured":"Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev. 2008, 60:470-512. 10.1124\/pr.108.000604","journal-title":"Pharmacol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis T","year":"2010","unstructured":"Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med. 2010, 152:93-100. 10.7326\/0003-4819-152-2-201001190-00008","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2015.11.02.90","article-title":"Ghrelin - physiological functions and regulation","volume":"11","author":"Ibrahim Abdalla MM","year":"2015","unstructured":"Ibrahim Abdalla MM. Ghrelin - physiological functions and regulation. Eur Endocrinol. 2015, 11:90-5. 10.17925\/EE.2015.11.02.90","journal-title":"Eur Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116011-weight-loss-of-over-100-lbs-in-a-patient-of-prader-willi-syndrome-treated-with-glucagon-like-peptide-1-glp-1-agonists","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:53Z","timestamp":1707508313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116011-weight-loss-of-over-100-lbs-in-a-patient-of-prader-willi-syndrome-treated-with-glucagon-like-peptide-1-glp-1-agonists"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.35102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,17]]}}}